CLASS II ONGOING Device recall · Reported 21 Jan 2026 · FDA Enforcement Report

Palacos MV+G pro recalled by Heraeus Medical GmbH (Dental

Heraeus Medical GmbH (Dental Division) is recalling Palacos MV+G pro 40. The recall was initiated on 9 Dec 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Code: UDI-DI: 04260102136243; 04260102136274

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1082-2026
FDA event ID
98078
Classification
Class II
Status
Ongoing
Recall initiated
9 Dec 2025
FDA classified
14 Jan 2026
Reported
21 Jan 2026
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction
Device type
Medical Software

Timeline

9 Dec 2025Recall initiated by company
14 Jan 2026Classified by FDA+36 days
21 Jan 2026Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

increase of complaints regarding the breakage of the ampoules within their device systems. An extensive investigation revealed that multiple factors have an impact on the ampoule breakage. An unfortunate combination of these influence factors can lead to unbreakable ampoules. If none or not all ampoules break, the product cannot be used on the patient since no or no appropriate cement dough is formed.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Brand Name: PALACOS Product Name: PALACOS MV+G pro 40; PALACOS MV+G pro 80 Model/Catalog Number: 5081290; 5081291 Software Version: N/A Product Description: Radiopaque, poly(methyl methacrylate)-based (PMMA) bone cement, pre-filled into a mixing and application system, suitable for use with or without vacuum (ready to mix). Component: N/A

Where it was distributed

International distribution in the countries of Aland Islands, Australia, Belgium, Denmark, Finland, Germany, Ireland, Italy, Liechtenstein, Netherlands, New Zealand, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom.

Questions about this recall

Why was it recalled?

increase of complaints regarding the breakage of the ampoules within their device systems. An extensive investigation revealed that multiple factors have an impact on the ampoule breakage. An unfortunate combination of these influence factors can lead to unbreakable ampoules. If none or not all ampoules break, the product cannot be used on the patient since no or no appropriate cement dough is formed.

Which lots are affected?

Lot Code: UDI-DI: 04260102136243; 04260102136274

Where was it sold?

International distribution in the countries of Aland Islands, Australia, Belgium, Denmark, Finland, Germany, Ireland, Italy, Liechtenstein, Netherlands, New Zealand, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

3 other products · FDA event 98078

This product is part of a recall event; the main page for the event is Palacos R+G pro recalled by Heraeus Medical GmbH (Dental.

More recalls from Heraeus Medical GmbH (Dental Division)

All 6

Other Medical Software recalls

All 903